PAVmed Inc
NASDAQ Capital MarketTotal Valuation
PAVmed Inc carries a market capitalization of 11,923.00, placing it among publicly traded companies globally. Its enterprise value stands at -228,000.00, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 11,923.00 |
| Enterprise Value | -228,000.00 |
Share Statistics
PAVmed Inc currently has 6.27M shares outstanding.
| Shares Outstanding | 6.27M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Enterprise Valuation
| EV / Sales | 1,183.61 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
PAVmed Inc maintains a current ratio of 2.02, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 68.07, indicating elevated leverage, while an interest coverage ratio of -1,187.45 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.02 |
| Quick Ratio | 1.77 |
| Debt / Equity | 68.07 |
| Debt / EBITDA | -0.72 |
| Interest Coverage | -1,187.45 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -37.92 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.11 |
Stock Price Statistics
PAVmed Inc's stock has declined approximately -97.76119% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.02.
| Beta (5Y) | N/A |
| 52-Week Price Change | -97.76119% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -23.75M, while operating income came in at -23.83M.
| Revenue | 85,000.00 |
| Gross Profit | -193,000.00 |
| Operating Income | -23.83M |
| Pretax Income | -22.16M |
| Net Income | -18.63M |
| EBITDA | -23.75M |
| EBIT | -23.83M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
PAVmed Inc holds 6.46M in cash and equivalents against 17.01M in total debt, resulting in a net debt position of 8.44M. Total book value stands at -259.02M, with working capital of 3.75M providing operational flexibility.
| Cash & Cash Equivalents | 6.46M |
| Total Debt | 17.01M |
| Net Debt | 8.44M |
| Equity (Book Value) | -259.02M |
| Book Value Per Share | N/A |
| Working Capital | 3.75M |
Cash Flow
PAVmed Inc produced -6.24M in operating cash flow over the past twelve months.
| Operating Cash Flow | -6.24M |
| Capital Expenditures | -47,000.00 |
| Free Cash Flow | -6.29M |
| FCF Per Share | N/A |
Margins
PAVmed Inc operates with a gross margin of -227.06, reflecting its pricing power and cost economics. The operating margin of -28,036.47 and net profit margin of -21,914.12 provide insight into operational efficiency.
| Gross Margin | -227.06 |
| Operating Margin | -28,036.47 |
| Pretax Margin | -26,065.88 |
| Profit Margin | -21,914.12 |
| EBITDA Margin | -27,940.00 |
Dividends & Yields
The company's payout ratio of 27.68 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | 27.68 |
| Shareholder Yield | N/A |
| FCF Yield | N/A |
Scores
PAVmed Inc posts an Altman Z-Score of -9.61, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -9.61 |